什麼是 SEC Form 13F 申報?美股機構大戶持股全攻略
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制,學會如何追蹤頂級對沖基金與機構法人持倉動向。
CIK: 0001920938
申報總市值
US$27.0億
US$27.0億
73 檔
27.7%
Q4 2025 季度申報顯示,Braidwell LP 揭露的美股組合總市值為 US$27.0億,涵蓋 73 個不同之權益投資部位。
Braidwell LP 在 Q4 2025 的調整主要集中於風險出清,清倉與減碼部位合計達 52 檔,反映機構對當前市場環境或個別公司估值採取較為保留之看法。
檢視投資組合結構,前 5 大主力部位(包含 CAI, GH 1.25 02-15-31, EWTX)占據了總市值的 27.7%,展現出該機構在 Q4 2025 的重點資金聚焦與風險分佈特徵。
| # | 代號 | 標的名稱 | 資產子類別 | 佔比 | 佔比變動 | 持倉量變化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CAI | Caris Life Sciences Inc | 股票-其他 | 6.74% | +0.66% | +6.83% | |
| 2 | GH 1.25 02-15-31債券 | Guardant Health Inc | 債券 | 6.15% | -3.42% | EXIT | |
| 3 | EWTX | Edgewise Therapeutics Inc | 股票-其他 | 4.14% | +0.53% | — | |
| 4 | RGEN 1 12-15-28債券 | Repligen CORP | 債券 | 3.54% | -2.68% | — | |
| 5 | NBIX | Neurocrine Biosciences Inc | 股票-醫療保健 | 3.41% | -0.77% | -14.63% | |
| 6 | GKOS | Glaukos CORP | 股票-醫療保健 | 3.33% | +0.32% | +18.18% | |
| 7 | NEO 0.25 01-15-28債券 | Neogenomics Inc | 債券 | 2.87% | -2.44% | — | |
| 8 | NUVL | Nuvalent Inc-a | 股票-其他 | 2.64% | -2.39% | EXIT | |
| 9 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 2.62% | -0.07% | -49.37% | |
| 10 | CGON | Cg Oncology Inc | 股票-其他 | 2.48% | -2.22% | EXIT | |
| 11 | IRTC 1.5 09-01-29債券 | Irhythm Holdings Inc | 債券 | 2.33% | — | -16.13% | |
| 12 | HNGE | Hinge Health Inc-a | 股票-其他 | 1.94% | +2.21% | +43.29% | |
| 13 | ALGN | Align Technology Inc | 股票-醫療保健 | 1.90% | — | -7.00% | |
| 14 | KOD | Kodiak Sciences Inc | 股票-其他 | 1.85% | +0.27% | — | |
| 15 | SLNOEUR | Soleno Therapeutics Inc | 股票-其他 | 1.76% | -1.07% | EXIT | |
| 16 | 260 | Centessa Pharmaceuticals-adr | 股票-其他 | 1.75% | -2.63% | EXIT | |
| 17 | NEO | Neogenomics Inc | 股票-醫療保健 | 1.74% | +1.26% | +161.57% | |
| 18 | ACAD | Acadia Pharmaceuticals Inc | 股票-醫療保健 | 1.74% | -0.30% | -14.57% | |
| 19 | SYRE | Spyre Therapeutics Inc | 股票-其他 | 1.71% | +1.32% | -36.60% | |
| 20 | DNTH | Dianthus Therapeutics Inc | 股票-其他 | 1.68% | -0.38% | +52.56% | |
| 21 | IRWD 1.5 06-15-26債券 | Ironwood Pharmaceuticals | 債券 | 1.61% | — | -34.98% | |
| 22 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 1.61% | -0.83% | +214.03% | |
| 23 | INSP | Inspire Medical Systems Inc | 股票-醫療保健 | 1.60% | -0.05% | -38.80% | |
| 24 | KRYS | Krystal Biotech Inc | 股票-醫療保健 | 1.59% | +0.20% | -61.16% | |
| 25 | ISRG | Intuitive Surgical Inc | 股票-醫療保健 | 1.51% | -0.16% | -35.94% | |
| 26 | TMO | Thermo Fisher Scientific Inc | 股票-醫療保健 | 1.50% | +0.14% | -29.15% | |
| 27 | BTSG | Brightspring Health Services | 股票-其他 | 1.43% | +0.10% | — | |
| 28 | CVS | Cvs Health CORP | 股票-醫療保健 | 1.43% | -0.70% | EXIT | |
| 29 | APGE | Apogee Therapeutics Inc | 股票-其他 | 1.39% | -1.34% | EXIT | |
| 30 | NRIX | Nurix Therapeutics Inc | 股票-其他 | 1.32% | +0.24% | — | |
| 31 | VERA | Vera Therapeutics Inc | 股票-其他 | 1.27% | +0.20% | +66.00% | |
| 32 | IRTC | Irhythm Holdings Inc | 股票-醫療保健 | 1.23% | +0.48% | -3.76% | |
| 33 | TMDX | Transmedics Group Inc | 股票-醫療保健 | 1.23% | +0.41% | -10.22% | |
| 34 | BMRN | Biomarin Pharmaceutical Inc | 股票-醫療保健 | 1.14% | -0.94% | EXIT | |
| 35 | ILMN | Illumina Inc | 股票-醫療保健 | 1.13% | -0.94% | EXIT | |
| 36 | KYMR | Kymera Therapeutics Inc | 股票-其他 | 1.13% | +0.66% | +64.17% | |
| 37 | FULC | Fulcrum Therapeutics Inc | 股票-其他 | 1.11% | -0.80% | EXIT | |
| 38 | PEN | Penumbra Inc | 股票-醫療保健 | 1.10% | -1.15% | EXIT | |
| 39 | MBX | Mbx Biosciences Inc | 股票-其他 | 1.03% | -0.04% | — | |
| 40 | RAPT | Rapt Therapeutics Inc | 股票-其他 | 1.01% | — | — | |
| 41 | CDNA | Caredx Inc | 股票-其他 | 0.96% | +0.03% | -27.38% | |
| 42 | DYN | Dyne Therapeutics Inc | 股票-其他 | 0.92% | -0.26% | -45.86% | |
| 43 | ✓ | Engene Holdings Inc | 股票-其他 | 0.90% | -0.56% | EXIT | |
| 44 | LEGN | Legend Biotech Corp-adr | 股票-其他 | 0.90% | — | -28.91% | |
| 45 | MRVI | Maravai Lifesciences Hldgs-a | 股票-其他 | 0.87% | +1.04% | — | |
| 46 | DHR | Danaher CORP | 股票-醫療保健 | 0.87% | +0.18% | -61.78% | |
| 47 | ARGX | Argenx Se - Adr | 股票-醫療保健 | 0.83% | -1.46% | -59.25% | |
| 48 | NTRA | Natera Inc | 股票-醫療保健 | 0.82% | -0.06% | — | |
| 49 | DRUG | Bright Minds Biosciences Inc | 股票-其他 | 0.81% | -0.05% | +6.81% | |
| 50 | 430 | Terns Pharmaceuticals Inc | 股票-其他 | 0.74% | — | — |
| # | 代號 | 標的名稱 | 佔比變動 | 持倉量變化 | 異動類型 |
|---|---|---|---|---|---|
| 1 | EWTX | Edgewise Therapeutics Inc | +1.6% | — | 不變 |
| 2 | GKOS | Glaukos CORP | +1.4% | +18.18% | 加碼 |
| 3 | NEO | Neogenomics Inc | +1.3% | +161.57% | 加碼 |
| 4 | CLDX | Celldex Therapeutics Inc | +1.2% | +214.03% | 加碼 |
| 5 | FULC | Fulcrum Therapeutics Inc | +1.1% | +1294.71% | 加碼 |
| 6 | VERA | Vera Therapeutics Inc | +0.9% | +66.00% | 加碼 |
| 7 | DNTH | Dianthus Therapeutics Inc | +0.7% | +52.56% | 加碼 |
| 8 | KYMR | Kymera Therapeutics Inc | +0.7% | +64.17% | 加碼 |
| 9 | HNGE | Hinge Health Inc-a | +0.6% | +43.29% | 加碼 |
| 10 | RGEN 1 12-15-28債券 | Repligen CORP | +0.5% | — | 不變 |
| 11 | CVS | Cvs Health CORP | +0.5% | +28.64% | 加碼 |
| 12 | ✓ | Engene Holdings Inc | +0.4% | +38.17% | 加碼 |
| 13 | SYRE | Spyre Therapeutics Inc | +0.4% | -36.60% | 減碼 |
| 14 | ALGN | Align Technology Inc | +0.4% | -7.00% | 減碼 |
| 15 | SRZN | Surrozen Inc | +0.3% | +235.71% | 加碼 |
| 16 | BMRN | Biomarin Pharmaceutical Inc | +0.3% | +13.92% | 加碼 |
| 17 | NEO 0.25 01-15-28債券 | Neogenomics Inc | +0.3% | — | 不變 |
| 18 | TECX | Tectonic Therapeutic Inc | +0.3% | +25.87% | 加碼 |
| 19 | DRUG | Bright Minds Biosciences Inc | +0.3% | +6.81% | 加碼 |
| 20 | ACAD | Acadia Pharmaceuticals Inc | +0.2% | -14.57% | 減碼 |
| 21 | ✓ | Zura Bio LTD | +0.2% | +28.61% | 加碼 |
| 22 | CAI | Caris Life Sciences Inc | +0.2% | +6.83% | 加碼 |
| 23 | MRVI | Maravai Lifesciences Hldgs-a | +0.2% | — | 不變 |
| 24 | IRTC | Irhythm Holdings Inc | +0.1% | -3.76% | 減碼 |
| 25 | TMDX | Transmedics Group Inc | +0.1% | -10.22% | 減碼 |
| 26 | NUVL | Nuvalent Inc-a | 0% | -18.91% | 減碼 |
| 27 | PEN | Penumbra Inc | 0% | -22.17% | 減碼 |
| 28 | CDNA | Caredx Inc | 0% | -27.38% | 減碼 |
| 29 | KIDS | Orthopediatrics CORP | 0% | -0.67% | 減碼 |
| 30 | LUNG | Pulmonx CORP | 0% | — | 不變 |
| 31 | HROW | Harrow Inc | 0% | -13.76% | 減碼 |
| 32 | DYN | Dyne Therapeutics Inc | -0.1% | -45.86% | 減碼 |
| 33 | TMO | Thermo Fisher Scientific Inc | -0.1% | -29.15% | 減碼 |
| 34 | ADPT | Adaptive Biotechnologies | -0.2% | -57.61% | 減碼 |
| 35 | IRTC 1.5 09-01-29債券 | Irhythm Holdings Inc | -0.2% | -16.13% | 減碼 |
| 36 | XNCR | Xencor Inc | -0.2% | -63.16% | 減碼 |
| 37 | ISRG | Intuitive Surgical Inc | -0.2% | -35.94% | 減碼 |
| 38 | NBIX | Neurocrine Biosciences Inc | -0.3% | -14.63% | 減碼 |
| 39 | APGE | Apogee Therapeutics Inc | -0.3% | -60.03% | 減碼 |
| 40 | KNSA | Kiniksa Pharmaceuticals International, plc | -0.3% | -51.21% | 減碼 |
| 41 | CSTL | Castle Biosciences Inc | -0.3% | -78.46% | 減碼 |
| 42 | INSP | Inspire Medical Systems Inc | -0.4% | -38.80% | 減碼 |
| 43 | RGEN | Repligen CORP | -0.4% | -58.20% | 減碼 |
| 44 | IRWD 1.5 06-15-26債券 | Ironwood Pharmaceuticals | -0.6% | -34.98% | 減碼 |
| 45 | ORKA | Oruka Therapeutics Inc | -0.7% | -93.87% | 減碼 |
| 46 | SLNOEUR | Soleno Therapeutics Inc | -0.8% | -7.34% | 減碼 |
| 47 | ARGX | Argenx Se - Adr | -0.8% | -59.25% | 減碼 |
| 48 | LEGN | Legend Biotech Corp-adr | -0.9% | -28.91% | 減碼 |
| 49 | DHR | Danaher CORP | -1% | -61.78% | 減碼 |
| 50 | KRYS | Krystal Biotech Inc | -1.1% | -61.16% | 減碼 |
根據 SEC 官方 Form 13F 申報備案,Braidwell LP 在 Q4 2025 季度的美股持倉總市值約為 US$27.0億,共申報了 73 個公開持股部位。
在 Q4 2025 季度,Braidwell LP 按市值排列的前三大核心持股分別為:CAI (6.7%)、GH 1.25 02-15-31 (6.2%)、EWTX (4.1%)。其中最大持股部位 CAI 佔據整體投資組合約 6.7% 的權重。
精選 AlphaSMO 大戶持股與內部人交易深度分析,提升投資決策勝率
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制,學會如何追蹤頂級對沖基金與機構法人持倉動向。
本季最大新建倉標的
KOD
市值: US$5795.5萬
本季最大獲利了結 / 清倉標的
NVCR 0 11-01-25
前期市值: US$2.1億
在 Q4 2025 季度中,Braidwell LP 共進行了 88 項持倉異動,包含新建倉 20 個部位、加碼 16 個部位、減碼 32 個部位以及清倉 20 個部位。 其中最大新建倉標的為 KOD。 本季清倉部位包含 NVCR 0 11-01-25。
本頁面所有持股數據均直接同步自美國證券交易委員會(SEC)EDGAR 官方系統之 13F-HR / 13F-HR/A 季度申報文件。AlphaSMO 透過機器解析 CUSIP 與個股對照,提供 100% 精準對齊的歷史時序數據集,並支援 Schema.org 結構化資料格式。
解析公司高管、董事與 10% 大股東之 Form 4 內部人交易申報,掌握高管自家股票買賣第一手訊號。
深入剖析 5% 股益申報門檻、13D 與 13G 之差異,以及最新 SEC 申報時程規範,洞察機構法人的激進投資動向。